{"schema_version":"secwatch.filing_event.v1","accession":"0001077183-23-000068","form_type":"8-K","ticker":"NEO","cik":"0001077183","company_name":"NEOGENOMICS INC","filed_at":"2023-05-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:37.871568+00:00","generated_at":"2026-06-14T11:12:46.223055+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"confidence":"high","headline":"NeoGenomics annual meeting: all directors elected; say-on-pay passes with 51.79% support","bullets":["Eight directors elected with votes For ranging from 97.2M (Kelly) to 105.7M (Smith).","Advisory say-on-pay passed narrowly: 51.79% For, 45.37% Against, 2.84% Abstain.","2023 Equity Incentive Plan approved by 95.28% of votes cast (100.8M For).","Ratification of independent auditor approved with 99.82% (113.2M For)."],"urls":{"canonical":"https://secwatch.observer/filing/0001077183-23-000068","json":"https://secwatch.observer/filing/0001077183-23-000068.json","markdown":"https://secwatch.observer/filing/0001077183-23-000068.md","text":"https://secwatch.observer/filing/0001077183-23-000068.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1077183/000107718323000068/0001077183-23-000068-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1077183/000107718323000068/neo-20230525.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T11:12:46.223055+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3f6d6c3a9d9db5247424dc80d2f7b184f5124330","claim":"NEOGENOMICS INC shareholders approved Approval of NeoGenomics, Inc. 2023 Equity Incentive Plan at the 2023-05-25 meeting.","evidence_excerpt":"Number of Votes Outstanding % Voted % For 100,799,248 79.02% 95.28% Against 4,930,366 3.86% 4.67% Abstentions 52,732 0.04% 0.05%","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718323000068/0001077183-23-000068-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-05-25"}],"fact_type":"shareholder_vote"},{"claim_id":"65873b760eb9a04052aecf6cc82fdfa2091e192e","claim":"NEOGENOMICS INC shareholders approved Advisory approval of compensation paid to Named Executive Officers at the 2023-05-25 meeting.","evidence_excerpt":"Number of Votes Outstanding % Voted % For 54,790,033 42.95% 51.79% Against 47,993,647 37.62% 45.37% Abstentions 2,998,666 2.35% 2.84%","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718323000068/0001077183-23-000068-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-05-25"}],"fact_type":"shareholder_vote"},{"claim_id":"e3231bacb44ff775cd68615658c1daec648ead56","claim":"NEOGENOMICS INC shareholders approved Election of eight directors to serve until the next annual meeting at the 2023-05-25 meeting.","evidence_excerpt":"Lynn A. Tetrault 100,261,190 5,521,156 — 7,610,467 Christopher M. Smith 105,547,399 234,947 — 7,610,467 Bruce K. Crowther 99,204,967 6,577,379 — 7,610,467 Dr. Alison L. Hannah 104,720,275 1,062,071 — 7,610,467 Stephen M. Kanovsky 104,579,362 1,202,984 — 7,610,467 Michael A. Kelly 97,173,743 8,608,603 — 7,610,467 David B. Perez 105,656,424 125,922 — 7,610,467 Rachel A. Stahler 104,833,843 948,503 — 7,610,467","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718323000068/0001077183-23-000068-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-05-25"}],"fact_type":"shareholder_vote"},{"claim_id":"e826cf36a36804f4d645b142e4a726b5a8ca3304","claim":"NEOGENOMICS INC shareholders approved Ratification of appointment of independent registered public accountant at the 2023-05-25 meeting.","evidence_excerpt":"Number of Votes Outstanding % Voted % For 113,191,746 88.73% 99.82% Against 163,098 0.12% 0.14% Abstentions 37,969 0.02% 0.04%","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718323000068/0001077183-23-000068-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-05-25"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}